Delivery Order SPE2DB22D3009-SPE2DB25FAK27

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,576.96 under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,566,555,940 units of the medication Duloxetine HCL DR 40 MG capsules. This contract supports the procurement of essential pharmaceutical products and medical supplies for military healthcare programs,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,075.05, is a delivery order for 4,565,218,418 units of Duloxetine HCl DR 60 mg capsules. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,906.41 fixed-price delivery order contract is for the supply of Duloxetine HCL DR 60 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,879.03, is a Firm Fixed Price Delivery Order for the supply of 4,563,061,891 units of Duloxetine HCL DR 60 MG Capsules. The award supports the DLA's medical supply chain, which provides essential pharmaceutical and medical products to military treatment facilities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.25 firm fixed-price delivery order is for the supply of 4566789424 - Duloxetine HCL DR 40 MG capsules, with a completion date of December 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,463.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,851,880 units of Duloxetine HCL DR 60 MG capsules. The award was made under a Delivery Order contract type with a Firm Fixed Price pricing structure. The ultimate completion date for this order is September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Duloxetine HCL DR 40 mg capsules. The contract is a delivery order with a firm fixed price of $1,342.68 and an ultimate completion date of December 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,460.42, is for the delivery of 4,567,793,444 units of the medication Duloxetine HCL DR 30 MG CAP. The contract is a firm fixed price delivery order with an ultimate completion date of April 4, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award....
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $1,991.97 Delivery Order, is for the supply of 4,567,887,153 units of Duloxetine HCL DR 60 MG capsules. The contract has an ultimate completion date of April 14, 2025 and is a Firm Fixed Price contract type. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,698.09 firm fixed-price contract is for the supply of 90-count capsules of the prescription medication Duloxetine HCl DR 60 mg. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAK27
    Delivery Order

The federal contract award SPE2DB22D3009|SPE2DB25FAK27 was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,352.29, is a Firm Fixed Price Delivery Order for 4,566,518,226 units of Duloxetine HCL DR 60 MG capsules.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

The contract award was not designated with any set-aside requirements, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 5/20/25, 2:04 PM